A recent 2,203 patient randomized trial conducted at VA hospitals has revealed that, despite the technical challenges of performing coronary artery bypass grafting procedures "off-pump" — i.e., without the use of cardiopulmonary bypass — and despite the perceived benefits of the procedure, off-pump procedures fare no better than on-pump procedures. Indeed the trend toward better [...]
In addition to bare metal, drug-eluting and absorbable stents on the market or under development for the treatment of coronary artery diseases, innovative companies have developed other types of stents to treat cardiovascular disease. These include bioactive coatings, antibody coatings, biomimetic coatings, hydrophilic coatings, titanium-nitride-oxide coatings, pericardium-covered stents, radioactive stents, synthetic graft alternatives, tissue engineered coatings, stents [...]
Coronary stents represent a worldwide market in the $billions due to their potential to address coronary artery disease without the invasive sternotomy, while demonstrating outcomes that rival coronary artery bypass graft procedures, particularly for advanced drug-eluting coronary stents. Given the financial stakes in the coronary stent market, it has driven the proliferation of competitors seeking [...]
Contact:
